Development and Pilot Validation of the DuMAND Checklist to Screen for Duchenne Muscular Dystrophy-Associated Neurobehavioral Difficulties (DuMAND)
Journal of Neuromuscular Diseases · 2024
DOI: 10.3233/jnd-240012 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Neuromuscular Diseases, 2024. Verfasst von Sam Geuens und 4 weiteren Autor:innen. Beteiligte Einrichtung: UZ Leuven, Child Neurology, Leuven, Belgium. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Checklist. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Patients with Duchenne muscular dystrophy (DMD) face a higher risk of neurobehavioral problems, yet an international consensus on screening, assessing, and managing these difficulties is lacking.
Objective
This report introduces the term Duchenne Muscular Dystrophy-Associated Neurobehavioral Difficulties (DuMAND) to comprehensively cover the spectrum of neurobehavioral issues in DMD patients, including behavior, psychiatric disorders, and various cognitive, academic, and psychosocial deficits. To facilitate screening, the DuMAND Checklist, a 43-item tool with five subscales, was developed. Methods and results: DuMAND categories were derived through literature review, parent (48 mothers and 37 fathers), and expert ( n = 28) input and feedback. The DuMAND Checklist subscales were developed iteratively, incorporating item selection, expert panel ( n = 10) assessment for face validity, comprehensiveness, and a pilot validation study in a DMD sample ( n = 20). DuMAND encompasses five categories: cognition and learning, social responsiveness, emotion regulation, externalizing behavior, and eating and sleeping. Preliminary validation of the DuMAND Checklist indicates acceptable-to-excellent internal consistency and construct validity.
Conclusion
By introducing the DuMAND concept, this study seeks to inspire a consensus approach for screening, assessing, and managing neurobehavioral issues in DMD. Incorporating screening, using the DuMAND Checklist, in addition to medical follow-up will facilitate early intervention, addressing a critical gap in identification of neurobehavioral disorders in DMD. Future research is needed to further evaluate psychometric properties of the DuMAND Checklist and investigate the natural course of DuMAND.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UZ Leuven, Child Neurology, Leuven, Belgium.
- Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
- UZ Leuven, Pediatric Hemato-Oncology, Leuven, Belgium.
- Department Oncology, KU Leuven, Pediatric Oncology, Leuven, Belgium.
- Leiden University Medical Center, Radiology, Leiden, Netherlands.
Zitieren
APA
Geuens, S., Goemans, N., Lemiere, J., Doorenweerd, N., & De Waele, L. (2024). Development and Pilot Validation of the DuMAND Checklist to Screen for Duchenne Muscular Dystrophy-Associated Neurobehavioral Difficulties (DuMAND). Journal of Neuromuscular Diseases. https://doi.org/10.3233/jnd-240012
Vancouver
Geuens S, Goemans N, Lemiere J, Doorenweerd N, De Waele L. Development and Pilot Validation of the DuMAND Checklist to Screen for Duchenne Muscular Dystrophy-Associated Neurobehavioral Difficulties (DuMAND). Journal of Neuromuscular Diseases. 2024. doi:10.3233/jnd-240012
BibTeX
@article{Geuens2024,
author = {Geuens, Sam and Goemans, Nathalie and Lemiere, Jurgen and Doorenweerd, Nathalie and De Waele, Liesbeth},
title = {Development and Pilot Validation of the DuMAND Checklist to Screen for Duchenne Muscular Dystrophy-Associated Neurobehavioral Difficulties (DuMAND)},
journal = {Journal of Neuromuscular Diseases},
year = {2024},
doi = {10.3233/jnd-240012}
}
EUVIMED